116 related articles for article (PubMed ID: 21084448)
1. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.
Caprio M; Antelmi A; Chetrite G; Muscat A; Mammi C; Marzolla V; Fabbri A; Zennaro MC; Fève B
Endocrinology; 2011 Jan; 152(1):113-25. PubMed ID: 21084448
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.
Armani A; Cinti F; Marzolla V; Morgan J; Cranston GA; Antelmi A; Carpinelli G; Canese R; Pagotto U; Quarta C; Malorni W; Matarrese P; Marconi M; Fabbri A; Rosano G; Cinti S; Young MJ; Caprio M
FASEB J; 2014 Aug; 28(8):3745-57. PubMed ID: 24806198
[TBL] [Abstract][Full Text] [Related]
3. Conception and pharmacodynamic profile of drospirenone.
Elger W; Beier S; Pollow K; Garfield R; Shi SQ; Hillisch A
Steroids; 2003 Nov; 68(10-13):891-905. PubMed ID: 14667981
[TBL] [Abstract][Full Text] [Related]
4. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.
Caprio M; Fève B; Claës A; Viengchareun S; Lombès M; Zennaro MC
FASEB J; 2007 Jul; 21(9):2185-94. PubMed ID: 17384139
[TBL] [Abstract][Full Text] [Related]
6. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
7. Drospirenone, a progestogen with antimineralocorticoid properties: a short review.
Oelkers W
Mol Cell Endocrinol; 2004 Mar; 217(1-2):255-61. PubMed ID: 15134826
[TBL] [Abstract][Full Text] [Related]
8. Effects of TWEAK (TNF superfamily member 12) on differentiation, metabolism, and secretory function of human primary preadipocytes and adipocytes.
Tiller G; Fischer-Posovszky P; Laumen H; Finck A; Skurk T; Keuper M; Brinkmann U; Wabitsch M; Link D; Hauner H
Endocrinology; 2009 Dec; 150(12):5373-83. PubMed ID: 19887572
[TBL] [Abstract][Full Text] [Related]
9. A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet.
Mammi C; Marzolla V; Armani A; Feraco A; Antelmi A; Maslak E; Chlopicki S; Cinti F; Hunt H; Fabbri A; Caprio M
Int J Obes (Lond); 2016 Jun; 40(6):964-72. PubMed ID: 26830012
[TBL] [Abstract][Full Text] [Related]
10. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
Rübig A
Climacteric; 2003 Oct; 6 Suppl 3():49-54. PubMed ID: 15018248
[TBL] [Abstract][Full Text] [Related]
11. Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells.
Sabouni R; Archer DF; Jacot T
Reprod Sci; 2021 Jul; 28(7):1974-1980. PubMed ID: 33559058
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
13. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
[TBL] [Abstract][Full Text] [Related]
14. Novel genes of visceral adiposity: identification of mouse and human mesenteric estrogen-dependent adipose (MEDA)-4 gene and its adipogenic function.
Zhang H; Chen X; Sairam MR
Endocrinology; 2012 Jun; 153(6):2665-76. PubMed ID: 22510272
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes.
Yang J; Ren J; Song J; Liu F; Wu C; Wang X; Gong L; Li W; Xiao F; Yan F; Hou X; Chen L
Int J Mol Med; 2013 Jun; 31(6):1429-35. PubMed ID: 23588664
[TBL] [Abstract][Full Text] [Related]
16. Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome.
Hsu HF; Tsou TC; Chao HR; Shy CG; Kuo YT; Tsai FY; Yeh SC; Ko YC
Toxicol Appl Pharmacol; 2010 Jun; 245(3):370-7. PubMed ID: 20406654
[TBL] [Abstract][Full Text] [Related]
17. Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage.
Miegueu P; Cianflone K; Richard D; St-Pierre DH
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E758-66. PubMed ID: 21771971
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitotic clonal expansion mediates fisetin-exerted prevention of adipocyte differentiation in 3T3-L1 cells.
Lee Y; Bae EJ
Arch Pharm Res; 2013 Nov; 36(11):1377-84. PubMed ID: 23918651
[TBL] [Abstract][Full Text] [Related]
19. Apigenin isolated from Daphne genkwa Siebold et Zucc. inhibits 3T3-L1 preadipocyte differentiation through a modulation of mitotic clonal expansion.
Kim MA; Kang K; Lee HJ; Kim M; Kim CY; Nho CW
Life Sci; 2014 Apr; 101(1-2):64-72. PubMed ID: 24582594
[TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone on the differentiation of bovine preadipocytes into adipocytes and the role of the signal transducer and activator of transcription 5b.
Zhao L; Wang A; Corl BA; Jiang H
J Anim Sci; 2014 May; 92(5):1958-67. PubMed ID: 24668956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
